Capturing Key MG-symptoms Using Smartphone Recordings.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLeiden University Medical Center
About this trial
This study will make use of a cross-sectional design of MG patients and non-MG participants to quantitatively assess key MG symptoms, and to explore the applicability of machine learning algorithms to their measurement.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Ability to understand the requirements of the study and provide written informed consent.
A clinical diagnosis of myasthenia gravis (ocular or generalized) as defined by the Dutch national guideline (category "definite" or "probable" MG).
MGFA Clinical Classification of disease severity I-IV.
Disqualifiers
Not willing to be audio-recorded for the study assessments.
Not willing to be video-recorded for the study assessments.
Subjects currently taking part in a clinical trial of an Investigational Medicinal Product.
Subjects who have used an immediate release pyridostigmine-based medication in the 12 hours prior to their participation and participants on prolonged release pyridostigmine.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
225 Participants
are grouped into 2 trial groupsSponsors and collaborators
Leiden University Medical Center
Lead sponsor
Huma
Collaborator
Source ClinicalTrials.gov